Most solutions to falsified medicine are built for the institutions that move it. RxLoop starts from the person who swallows it.
Serialisation, track-and-trace and authentication technology all exist and all work. They stop at the pharmacy counter. Beyond it sits the one participant who touches every pack, carries all the risk, and has no instrument at all: the patient.
RxLoop is the layer that gives that person something useful immediately, guidance they can read, a way to raise a hand, and, in doing so, creates the return channel the rest of the chain has never had.
If a feature does not work, it does not appear in the product, in a demo, or on this site as though it does. A mocked verification screen would demo beautifully and get someone killed.
The reference content carries general safety and adherence guidance only. Numbers that depend on a specific body do not belong in a general-purpose app.
Anything that only works on a good connection has excluded most of the people it claims to serve.
Revenue comes from pharmacies, manufacturers and regulators who get operational value from the return path. It never comes from selling an individual's health data.
Every reference entry needs a licensed pharmacist's sign-off, and every translation a native-speaking health communicator's, before any push for wide adoption.
Building RxLoop from Nigeria, for the pharmacies, patients and regulators who live with this problem daily rather than read about it in a market report.